Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

ARTL holding history

Artelo Biosciences, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARTL overviewAll 13F holders of ARTLFull Q2 2026 holdings

Shares (Q2 2026)
13,864
Value
$15.5K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ARTL by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,864$15.5K<0.1%+13,864NewHolders
Q1 20260$00.0%−11,398−100.0%Sold outHolders
Q4 202511,398$13.9K<0.1%+11,398NewHolders
Q3 20250$00.0%−16,032−100.0%Sold outHolders
Q2 202516,032$212.7K<0.1%−10,730−40.1%ReducedHolders
Q1 202526,762$23.4K<0.1%+9,412+54.2%AddedHolders
Q4 202417,350$18.4K<0.1%00.0%UnchangedHolders
Q3 202417,350$19.8K<0.1%−2,458−12.4%ReducedHolders
Q2 202419,808$27.7K<0.1%00.0%UnchangedHolders
Q1 202419,808$29.7K<0.1%00.0%UnchangedHolders
Q4 202319,808$27.5K<0.1%00.0%UnchangedHolders
Q3 202319,808$28.9K<0.1%+6,101+44.5%AddedHolders
Q2 202313,707$27.6K<0.1%00.0%UnchangedHolders
Q1 202313,707$31.8K<0.1%00.0%UnchangedHolders
Q4 202213,707$39.0K<0.1%+1,234+9.9%AddedHolders
Q3 202212,473$43.0K<0.1%−174,593−93.3%ReducedHolders
Q2 2022187,066$59.0K<0.1%+19,240+11.5%AddedHolders
Q1 2022167,826$75.0K<0.1%+5,076+3.1%AddedHolders
Q4 2021162,750$84.0K<0.1%00.0%UnchangedHolders
Q3 2021162,750$128.0K<0.1%+22,139+15.7%AddedHolders
Q2 2021140,611$167.0K<0.1%−662−0.5%ReducedHolders
Q1 2021141,273$230.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.